ETFMG Treatments Testing and Advancements ETF is a ETF series of ETF Managers Trust (series S000068972). Net assets $12.8M as of 2023-12-31. Index fund.
Showing 15 of 64 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Mount Vernon Liquid Assets Portfolio, LLC | — | $3.8M | 2994.60% |
| Moderna Inc | — | $872K | 682.53% |
| Alnylam Pharmaceuticals Inc | — | $776K | 606.74% |
| BioNTech SE | — | $717K | 560.52% |
| Laboratory Corp of America Hol | — | $714K | 558.85% |
| Quest Diagnostics Inc | — | $685K | 535.75% |
| ImmunityBio Inc | — | $620K | 484.98% |
| Immunocore Holdings PLC | — | $589K | 460.65% |
| Vaxcyte Inc | — | $551K | 431.25% |
| QuidelOrtho Corp | — | $487K | 381.21% |
| Bio-Rad Laboratories Inc | — | $481K | 376.37% |
| Dynavax Technologies Corp | — | $458K | 358.42% |
| Zai Lab Ltd | — | $455K | 356.04% |
| AbCellera Biologics Inc | — | $420K | 328.63% |
| Vir Biotechnology Inc | — | $343K | 268.42% |
| Report date | Net assets |
|---|---|
| 2023-12-31 | $12.8M |
| 2023-09-30 | $13.5M |
| 2023-06-30 | $17.6M |
| 2023-03-31 | $18.9M |
| 2022-12-31 | $24.2M |
| 2022-09-30 | $21.8M |
| 2022-06-30 | $25.7M |
| 2022-03-31 | $34.2M |